Screener
Charles River Laboratories CRL DSA — Goodwill, impaired, accumulated impairment loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
FAQ
- What is Charles River Laboratories's DSA — goodwill, impaired, accumulated impairment loss?
- Charles River Laboratories (CRL) reported DSA — goodwill, impaired, accumulated impairment loss of $1B in Q2 2026.
- How has Charles River Laboratories's DSA — goodwill, impaired, accumulated impairment loss changed year-over-year?
- Charles River Laboratories's DSA — goodwill, impaired, accumulated impairment loss decreased by 0.0% year-over-year, from $1B to $1B.
- What does DSA — goodwill, impaired, accumulated impairment loss mean?
- The cumulative total of all impairment charges recognized against the goodwill associated with this specific business segment. It reflects the historical reduction in the carrying value of acquired assets due to declines in their fair market value or business performance.
Ask your AI about Charles River Laboratories's dsa — goodwill, impaired, accumulated impairment loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude